Aurora Cannabis purchases 450,000 shares, or 1.8%, of CanniMed Therapeutics

FILE PHOTO - Cannabis seedlings are seen at the new Aurora Cannabis facility Friday, November 24, 2017 in Montreal.
Image Credit: THE CANADIAN PRESS/Ryan Remiorz

TORONTO - Aurora Cannabis Inc. (TSX:ACB) says it has purchased 450,000 common shares of CanniMed Therapeutics Inc. (TSX:CMED), equivalent to about 1.8 per cent of the company.

Vancouver-headquartered Aurora says it's allowed to buy up to about five per cent of the Saskatoon-headquartered company's stock on the open market and this is its first purchase.

An acrimonious takeover battle between the two marijuana companies was in the regulatory spotlight earlier in the month at a joint hearing involving the Saskatchewan and Ontario securities commissions.

Both have said they are pleased with a regulatory ruling — dated Dec. 22 but released Wednesday — that gives each of them some of what they were seeking.

Any securities issued by CanniMed as a defence against a hostile takeover by Aurora will be cease-traded, the Ontario Securities Commission said Wednesday.

The OSC said Aurora, for its part, will be required to amend its takeover bid circular and related press releases to include certain information that could affect CanniMed's shareholders when they decide to accept or reject the offer.

MANN: Springtime is all about getting outside
OPINION Spring officially started two days ago and it is hard not to smile. It is nice to open my door in the morning and not be blasted by freezing cold air or have to make an awkward sprint for my vehicle — awkward b

Top News